ARMP Stock Price, Chart, Stats & News

Armata Pharmaceuticals, Inc.
Save
Armata Pharmaceuticals, Inc. (ARMP) does not currently pay a dividend.
137.30M
Market cap
–
Current P/E
–
Forward P/E
ARMP chart
About
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform.
Similar securities
Based on sector and market capitalization
Report issue





